| Literature DB >> 29087624 |
Nicky O'Boyle1, James P R Connolly1, Andrew J Roe1.
Abstract
Type 3 secretion systems form an integral part of the arsenal of many pathogenic bacteria. These injection machines, together with their cargo of subversive effector proteins, are capable of manipulating the cellular environment of the host in order to ensure persistence of the pathogen. In order to fully appreciate the functions of Type 3 effectors, it is necessary to gain spatio-temporal knowledge of each effector during the process of infection. A number of genetic modifications have been exploited in order to reveal effector protein secretion, translocation and subsequent activity, and localisation within host cells. In this review, we will discuss the many available approaches for tracking effector protein dynamics and discuss the challenges faced to improve the current technologies and gain a clearer picture of effector protein function.Entities:
Keywords: effector; localisation; methods; protein; reporter; secretion
Mesh:
Substances:
Year: 2017 PMID: 29087624 PMCID: PMC5765406 DOI: 10.1111/cmi.12797
Source DB: PubMed Journal: Cell Microbiol ISSN: 1462-5814 Impact factor: 3.715
Figure 1Schematic summary of the principle methodologies for tracking effector proteins during infection. (a) Bulk assessment of translocation via effector‐CyaA fusion (Section 2.1). Effector translocation results in host cell calmodulin‐dependent cAMP accumulation, which can be measured by enzyme‐linked immunosorbent assay. (b) Immunofluorescent detection of epitope‐tagged effectors in fixed tissues (Section 2.2). The translocated effector can be detected using commercially available antibodies with specificity for the chosen epitope tag. (c) Detection of TEM‐1 β‐lactamase‐effector fusions via spectral shifting of the fluorescence resonance energy transfer substrate coumarin cephalosporin fluorescein (CCF2‐AM; Section 2.3). Cleavage of the CCF2‐AM substrate shifts the emission spectrum of the fluorophore from green to blue allowing detection of translocation with high sensitivity. (d) Analysis of subcellular localisation of untagged effectors via recruitment of host‐expressed chaperone‐green fluorescent protein (GFP) fusion (Section 2.4). An un‐tagged effector protein can be visualised in the host cell upon binding to its fluorescently labelled chaperone when ectopically expressed via transfection. (e) Direct 4Cys‐FlAsH labelling of effectors (Section 2.5). Bacteria can be preloaded with FlAsH dye, which binds to the 4Cys tag and emits green fluorescence, thereby allowing real‐time tracking of effector injection. (f) Tracking of effectors within the host cells using split‐GFP fluorescence complementation (Section 2.6). Fusion of the GFP11 β‐strand to the incomplete/inactive host‐expressed GFP1–10, results in fluorescence complementation, allowing indirect assessment of translocation. (g) Direct labelling of effectors with phiLOV (Section 2.7). The phiLOV tag binds flavin mononucleotide, emitting fluorescence in the green spectrum, which allows direct analysis of effector secretion. (h) Direct labelling of effectors with photo‐switchable fluorescent protein such as mEos3.2 for super‐resolution microscopy (Section 2.8). Photo‐switchable fluorescent tags allow for reversible transition between on and off states that yields spatial resolution beyond the diffraction limit of light